Periprosthetic bone density as outcome of therapeutic response
- PMID: 22461288
- PMCID: PMC2898003
Periprosthetic bone density as outcome of therapeutic response
Abstract
The bone surrounding a prosthetic implant normally experiences a progressive quantitative reduction as a result of stress shielding and wear debris production, that can lead to the aseptic loosening of the implant. Dual-energy X-ray absorptiometry (DXA), using software algorithms, can ensure a surrogate measure of load redistribution after the implant of the prosthetic components and can be a valid tool to evaluate the efficacy of pharmacological therapy to reduce the periprosthetic bone loss. In several animal and human studies DXA has been able to quantify antiresorptive action of bisphosphonates in the periprosthetic area.
Figures
References
-
- Malchau H, Herberts P, Eisler T, et al. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am. 2002;84-A(2):2–20. - PubMed
-
- Kröger H, Venesmaa P, Jurvelin J, et al. Bone density at the proximal femur after total hip arthroplasty. Clin Orthop Relat Res. 1998 Jul;(352):66–74. - PubMed
-
- Santavirta S, Hoikka V, Eskola A, et al. Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Joint Surg Br. 1990 Nov;72(6):980–4. - PubMed
-
- Sarmiento A, Gruen TA. Radiographic analysis of a low-modulus titanium-alloy femoral total hip component. Two to six-year follow-up. J Bone Joint Surg Am. 1985 Jan;67(1):48–56. - PubMed
-
- Tatsumi S, Ishii K, Amizuka N, et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 2007 Jun;5(6):464–75. - PubMed
LinkOut - more resources
Full Text Sources